Image of March 2025 EMBO journal cover
Members in the News

Boosting human immunology: harnessing the potential of immune organoids

Featured on the March 12, 2025 cover of EMBO Molecular Medicine, this recent publication, by Maximilian Moll and Prof. Dr. Dirk Baumjohann of the Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology at University Hospital Bonn titled, “Boosting human immunology: harnessing the potential of immune organoids” highlights scientific advances [READ MORE]

Annual Meeting

If You Only Attend One Meeting this Year, Here’s Why You Should Choose Cytokines 2025

The Cytokines Society Annual Meeting is the only international meeting focusing specifically on cytokine biology – covering basic, translational, and clinical research specific to the role of cytokines in health and diseases. This meeting provides researchers from academia, government and industry the opportunity for networking and to engage with global [READ MORE]

Congratulatory message and photos of four scientific award winners.
Amanda Proudfoot Tribute Award

Congratulations 2025 ICIS Young Investigators!

The International Cytokine & Interferon Society proudly announces these 2025 Young Investigator Award winners. The Sidney & Joan Pestka Graduate and Post-Graduate Awards, sponsored by PBL Assay Services Post-graduate awardee, Alexander Lercher, PhD, The Rockefeller University is currently an HFSP long-term fellow and Harvey L. Karp postdoctoral fellow in the [READ MORE]

No Picture
Clinical Trials

Interleukin23 in Systemic Lupus

ClinicalTrials.gov ID NCT06713187 Sponsor Sohag University Information provided by khadiga Mahmoud Salem, Sohag University (Responsible Party) Brief Summary Assessment of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease . Detailed Description for all patients detailed history taken clinical and rhumatological examination will be assessed [READ MORE]

No Picture
Clinical Trials

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

ClinicalTrials.gov ID NCT05035862 Sponsor Emory University Information provided by Edwin Horwitz, Emory University (Responsible Party) Brief Summary This study is a two strata, dose escalation Phase I clinical trial designed to assess the safety and determine the maximal tolerated dose (MTD) of allogenic cord tissue derived MSCs (cMSCs, stratum 1) [READ MORE]

No Picture
Clinical Trials

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier (Pregiferon)

ClinicalTrials.gov ID NCT06371235 Sponsor CerbaXpert Information provided by CerbaXpert (Responsible Party) Brief Summary The main objective of the study is to evaluate the frequency of placental transfer of self-Ab directed against the mother’s IFN alpha in the newborn, in all women suffering from a pathology frequently associated with the presence [READ MORE]